• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对阿片类药物替代治疗中使用海洛因的患者的社交网络干预的初步研究:一项随机对照试验的研究方案。

Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial.

机构信息

Birmingham & Solihull Mental Health Foundation Trust, Research & Innovation Department, Radclyffe House, 66-68 Hagley Road, Birmingham B16 8PF, UK.

出版信息

Trials. 2013 Aug 19;14:264. doi: 10.1186/1745-6215-14-264.

DOI:10.1186/1745-6215-14-264
PMID:23958332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3765136/
Abstract

BACKGROUND

Research indicates that 3% of people receiving opiate substitution treatment (OST) in the UK manage to achieve abstinence from all prescribed and illicit drugs within 3 years of commencing treatment, and there is concern that treatment services have become skilled at engaging people but not at helping them to enter a stage of recovery and drug abstinence. The National Treatment Agency for Substance Misuse recommends the involvement of families and wider social networks in supporting drug users' psychological treatment, and this pilot randomized controlled trial aims to evaluate the impact of a social network-focused intervention for patients receiving OST.

METHODS AND DESIGN

In this two-site, early phase, randomized controlled trial, a total of 120 patients receiving OST will be recruited and randomized to receive one of three treatments: 1) Brief Social Behavior and Network Therapy (B-SBNT), 2) Personal Goal Setting (PGS) or 3) treatment as usual. Randomization will take place following baseline assessment. Participants allocated to receive B-SBNT or PGS will continue to receive the same treatment that is routinely provided by drug treatment services, plus four additional sessions of either intervention. Outcomes will be assessed at baseline, 3 and 12 months. The primary outcome will be assessment of illicit heroin use, measured by both urinary analysis and self-report. Secondary outcomes involve assessment of dependence, psychological symptoms, social satisfaction, motivation to change, quality of life and therapeutic engagement. Family members (n = 120) of patients involved in the trial will also be assessed to measure the level of symptoms, coping and the impact of the addiction problem on the family member at baseline, 3 and 12 months.

DISCUSSION

This study will provide experimental data regarding the feasibility and efficacy of implementing a social network intervention within routine drug treatment services in the UK National Health Service. The study will explore the impact of the intervention on both patients receiving drug treatment and their family members.

TRIAL REGISTRATION NUMBER

ISRCTN22608399. ISRCTN22608399 registration: 27/04/2012. Date of first randomisation: 14/08/2012.

摘要

背景

研究表明,在英国接受阿片类药物替代治疗(OST)的人群中,有 3%的人在开始治疗的 3 年内成功戒除所有规定和非法药物,人们担心治疗服务已经擅长让人们参与,但不擅长帮助他们进入康复和戒除药物的阶段。国家药物滥用治疗机构建议让家庭和更广泛的社交网络参与支持吸毒者的心理治疗,这项试点随机对照试验旨在评估针对接受 OST 的患者的以社交网络为重点的干预措施的影响。

方法和设计

在这项两地点、早期阶段、随机对照试验中,将招募 120 名接受 OST 的患者,并将他们随机分配接受以下三种治疗之一:1)简短社交行为和网络治疗(B-SBNT),2)个人目标设定(PGS)或 3)常规治疗。随机化将在基线评估后进行。分配接受 B-SBNT 或 PGS 的参与者将继续接受药物治疗服务常规提供的相同治疗,外加另外四次干预。结果将在基线、3 个月和 12 个月时进行评估。主要结果将是通过尿液分析和自我报告评估非法海洛因使用情况。次要结果包括评估依赖、心理症状、社交满意度、改变动机、生活质量和治疗参与度。参与试验的患者的家庭成员(n=120)也将进行评估,以衡量基线、3 个月和 12 个月时家庭成员的症状、应对方式和成瘾问题对家庭成员的影响。

讨论

这项研究将提供有关在英国国民保健制度常规药物治疗服务中实施社交网络干预措施的可行性和疗效的实验数据。该研究将探讨干预措施对接受药物治疗的患者及其家庭成员的影响。

试验注册号

ISRCTN22608399。ISRCTN22608399 注册:2012 年 4 月 27 日。首次随机分组日期:2012 年 8 月 14 日。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/3765136/cc426f2ef147/1745-6215-14-264-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/3765136/cc426f2ef147/1745-6215-14-264-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb3e/3765136/cc426f2ef147/1745-6215-14-264-1.jpg

相似文献

1
Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial.一项针对阿片类药物替代治疗中使用海洛因的患者的社交网络干预的初步研究:一项随机对照试验的研究方案。
Trials. 2013 Aug 19;14:264. doi: 10.1186/1745-6215-14-264.
2
A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services.一项辅助性简短社交网络干预在阿片类药物替代治疗服务中的初步可行性随机对照试验。
BMC Psychiatry. 2018 Jan 15;18(1):8. doi: 10.1186/s12888-018-1600-7.
3
Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs - a randomised controlled feasibility trial.青少年社会行为与网络疗法(Y-SBNT):针对酒精和药物滥用青少年的家庭与社会网络干预措施的改编——一项随机对照可行性试验。
Health Technol Assess. 2017 Mar;21(15):1-260. doi: 10.3310/hta21150.
4
Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.针对物质滥用的戒断行为的正性强化(PRAISe):一项基于群组的随机对照试验及对效价管理的过程评估的研究方案
Contemp Clin Trials. 2018 Aug;71:124-132. doi: 10.1016/j.cct.2018.06.008. Epub 2018 Jun 13.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Mobile telephone-delivered Contingency Management (mCM) to reduce heroin use in individuals with opioid use disorder (CM4OUD): A feasibility study protocol.通过移动电话实施的应急管理(mCM)以减少阿片类物质使用障碍患者的海洛因使用(CM4OUD):一项可行性研究方案。
PLoS One. 2025 May 28;20(5):e0324516. doi: 10.1371/journal.pone.0324516. eCollection 2025.
7
Assertive Community Treatment for alcohol dependence (ACTAD): study protocol for a randomised controlled trial.针对酒精依赖的坚定社区治疗(ACTAD):一项随机对照试验的研究方案。
Trials. 2012 Feb 20;13:19. doi: 10.1186/1745-6215-13-19.
8
A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.一项旨在减少早期精神病患者大麻使用和复发时间的权变管理干预措施:CIRCLE RCT。
Health Technol Assess. 2019 Aug;23(45):1-108. doi: 10.3310/hta23450.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
The effects of a brief CBT intervention, delivered by frontline mental health staff, to promote recovery in people with psychosis and comorbid anxiety or depression (the GOALS study): study protocol for a randomized controlled trial.由一线心理健康工作人员提供的简短认知行为疗法干预对促进精神病合并焦虑或抑郁患者康复的效果(目标研究):一项随机对照试验的研究方案
Trials. 2014 Jun 27;15:255. doi: 10.1186/1745-6215-15-255.

引用本文的文献

1
Perceived difficulty of getting help to reduce or abstain from substances among sexual and gender minority men who have sex with men (SGMSM) and use methamphetamine during the early period of the COVID-19 pandemic.在 COVID-19 大流行早期,与男男性行为者(MSM)发生性行为且使用冰毒的性少数和性别少数男性(SGMSM),他们感知获得帮助减少或戒除物质的难度。
Subst Abuse Treat Prev Policy. 2021 Dec 13;16(1):88. doi: 10.1186/s13011-021-00425-3.
2
Individual variation in the attribution of incentive salience to social cues.个体差异在对社交线索的激励显著性归因中的表现。
Sci Rep. 2020 Feb 13;10(1):2583. doi: 10.1038/s41598-020-59378-5.
3

本文引用的文献

1
Exploring treatment attendance and its relationship to outcome in a randomized controlled trial of treatment for alcohol problems: secondary analysis of the UK Alcohol Treatment Trial (UKATT).探索治疗依从性及其与酒精问题治疗随机对照试验结局的关系:英国酒精治疗试验(UKATT)的二次分析。
Alcohol Alcohol. 2011 Sep-Oct;46(5):592-9. doi: 10.1093/alcalc/agr079. Epub 2011 Jul 5.
2
Development of a self-report measure of capability wellbeing for adults: the ICECAP-A.成人能力幸福感自评量表的研制:ICECAP-A。
Qual Life Res. 2012 Feb;21(1):167-76. doi: 10.1007/s11136-011-9927-2. Epub 2011 May 20.
3
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
Predicting health-related quality of life (EQ-5D-5 L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP.
运用常规临床结局评估工具(CORE-OM、LDQ 和 TOP)预测阿片类药物依赖患者的健康相关生活质量(EQ-5D-5L)和能力幸福感(ICECAP-A)
Health Qual Life Outcomes. 2018 May 30;16(1):106. doi: 10.1186/s12955-018-0926-7.
4
A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services.一项辅助性简短社交网络干预在阿片类药物替代治疗服务中的初步可行性随机对照试验。
BMC Psychiatry. 2018 Jan 15;18(1):8. doi: 10.1186/s12888-018-1600-7.
CONSORT 2010 声明:平行组随机试验报告的更新指南。
BMJ. 2010 Mar 23;340:c332. doi: 10.1136/bmj.c332.
4
Family members of people with alcohol or drug dependence: health problems and medical cost compared to family members of people with diabetes and asthma.酒精或药物依赖者的家庭成员:与糖尿病和哮喘患者的家庭成员相比的健康问题及医疗费用
Addiction. 2009 Feb;104(2):203-14. doi: 10.1111/j.1360-0443.2008.02447.x.
5
The Important People Drug and Alcohol interview: psychometric properties, predictive validity, and implications for treatment.重要人物药物与酒精访谈:心理测量特性、预测效度及对治疗的启示
J Subst Abuse Treat. 2009 Apr;36(3):321-30. doi: 10.1016/j.jsat.2008.08.001. Epub 2008 Oct 5.
6
Validation of a scale for rating the delivery of psycho-social treatments for alcohol dependence and misuse: the UKATT Process Rating Scale (PRS).用于评估酒精依赖和滥用心理社会治疗服务提供情况的量表验证:英国酒精治疗试验过程评定量表(PRS)。
Alcohol Alcohol. 2008 Nov-Dec;43(6):675-82. doi: 10.1093/alcalc/agn064. Epub 2008 Sep 25.
7
Development of the Treatment Outcomes Profile.治疗结果概况的制定。
Addiction. 2008 Sep;103(9):1450-60. doi: 10.1111/j.1360-0443.2008.02284.x.
8
What is recovery? A working definition from the Betty Ford Institute.什么是康复?贝蒂·福特研究所给出的一个实用定义。
J Subst Abuse Treat. 2007 Oct;33(3):221-8. doi: 10.1016/j.jsat.2007.06.001.
9
Family members of relatives with alcohol, drug and gambling problems: a set of standardized questionnaires for assessing stress, coping and strain.有酗酒、吸毒和赌博问题亲属的家庭成员:一套用于评估压力、应对方式和紧张程度的标准化问卷。
Addiction. 2005 Nov;100(11):1611-24. doi: 10.1111/j.1360-0443.2005.01178.x.
10
Cost effectiveness of treatment for alcohol problems: findings of the randomised UK alcohol treatment trial (UKATT).酒精问题治疗的成本效益:英国酒精治疗随机试验(UKATT)的结果
BMJ. 2005 Sep 10;331(7516):544. doi: 10.1136/bmj.331.7516.544.